Regional cerebral blood flow SPECT study, at rest and during Wisconsin Card Sorting Test (WCST) performance, in schizophrenia naive patients or treated with atypical neuroleptics

Actas Espanolas de Psiquiatria

Volumn 33, Issue 6, 2005, Pages 343-351

  Moreno Iniguez M ^a,b   Ortuno F ^a   Arbizu, J ^a   Millan M ^a   Soutullo, C ^a   Cervera Enguix, S ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Frontal cortex; PANSS; Schizophrenia; SPECT

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; BLOOD FLOW; FEMALE; FRONTAL LOBE; HEMISPHERIC DOMINANCE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; SCHIZOPHRENIA; SCINTISCANNING; VASCULARIZATION;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FRONTAL LOBE; FUNCTIONAL LATERALITY; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; REGIONAL BLOOD FLOW; SCHIZOPHRENIA;

EID: 28844495657     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Weinberger DR, Berman KF, Zec RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986;43:114-24.
2. Buchsbaum MS, Nuechterlein KH, Haier RJ. Glucose metabolic rate in normals and schizophrenics during the continuous performance test assessed by positron emission tomography. Br J Psychiatry 1990;156:216-27.
3. Andreasen NC, Rezai K, Alliger R. Hypofrontality in neuroleptic-naive and chronic schizophrenic patients: assessment with Xenon-133 single photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992;49:943-58.
4. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LI, et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 1997;349:1730-4.
5. Liddle PF, Morris DL. Schizophrenic syndromes and frontal lobe performance. Br J Psychiatry 1991;158:340-45.
6. Sabri O, Erkwoh R, Schreckenberger M, Owega A, Sass H, Buell U. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet 1997;349:1735-9.
7. Erkwoh R, Sabri O, Steinmeyer EM, Bull U, Sass H. Psychopathological and SPECT findings in never-treated schizophrenia. Acta Psychiatr Scand 1997;96:51-7.
8. Catafau AM, Parellada E, Lomeña F. Prefrontal and temporal blood flow in schizophrenia: resting and activation Technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease. J Nucl Med 1994;35:935-41.
9. Tien AY, Schlaepfer TE, Orr W, Pearlson GD. SPECT brain blood flow changes with continuous ligand infusion during previously learned WCST performance. Psychiatry Res 1998;82:47-52.
10. Paulman RG, Devous MD, Gregory RR, Herman JH, Jennings L, Bonte FJ, et al. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neurophysiological assessment of schizophrenic brain function. Biol Psychiatry 1990;27:377-99.
11. Hawton K, Shepstone B, Soper N, Reznek L. Single-photon emission computerized tomography (SPECT) in Schizophrenia. Br J Psychiatry 1990;156:425-7.
12. Erbas B, Kumbasar H, Erbengi G, Bekdik C. Tc-99m HMPAO/SPECT determination of regional cerebral blood flow changes in schizophrenics. Clin Nucl Med 1990;15:904-7.
13. Parellada E, Catafau AM, Bernardo M. Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: a resting and activation SPECT study. Psychiatry Res 1994;55:131-9.
14. Kay SR, Opler LA, Fiszbein A. The Positive and Negative Syndrome Scale (PANSS). Rating Manual. Social and Behavioral Science Documents 1984;17:28-9.
15. Peralta V, Cuesta MJ. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res 1994;53:31-40.
16. Annet M. A classification of hand preference by association analysis. Br J Psychology 1974;61:303-21.
17. Ortuño F, López P, Landecho I, Bonelli R. Estudio comparativo de la preferencia manual en pacientes esquizofrénicos mediante la versión española del cuestionario de preferencia manual de Annett. Int J Clin Pract [en prensa].
18. Parellada E, Catafau AM, Bernardo M. The resting and activation issue of hypofrontality: a single photon emission computed tomography study in neuroleptic-naive and neuroleptic-free schizophrenic female patients. Biol Psychiatry 1998;15;44:787-90.
19. Heaton RK. Wisconsin Card Sorting Test Manual. Odessa: Psychological Assessments Resources, 1993.
20. Van Horn JD, Ellmore TM, Esposito G, Berman KF. Mapping voxel-based statistical power on parametric images. Neuroimage 1998;87-107.
21. Volz HP, Hubner G, Rzanny R, Rossger G, Preussler B, Eichhorn M, et al. High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sorting Test performance in controls, not in schizophrenics: a 31 phosphorus magnetic resonance spectroscopic and neuropsychological investigation. Schizophr Res 1998;31:37-47.
22. Drevets WC. Neuroimaging and neuropathological studies of depression: implication for the cognitive emotional features of mood disorders. Curr Opin Neurobiol 2001;11:240-9.
23. Berman I, Merson A, Sison C. Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study. Psychopharmacol-Bull 1996;32:95-100.
24. Molina-Rodriguez-V, Montz-Andree R, Perez-Castejon MJ. SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine. Am J Psychiatry 1996;153:1343-6.
25. Rossi A, Mancini F, Stratta P. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study. Acta Psychiatr Scand 1997;95:40-3.
26. Meltzer D. Perspective and the measurement of costs and benefits for cost-effectiveness analysis in schizophrenia. J Clin Psychiatry 1999;60(Suppl. 3):32-7.
27. Perkins D, Lieberman J, Gu H, Tohen M, McEvoy J, Green A, et al. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry 2004;185:18-24.
28. McQueen GM, Galway T, Goldberg JO, Tipper P. Impaired distractor inhibition in patients with schizophrenia on a negative priming task. Psychological Med 2003;33:121-9.
29. Huettel SA, Obembe OO, Song AW, Woldorff MG. The BOLD fMRI refractory effect is specific to stimulus attributes: evidence from a visual motion paradigm. Neuroimage 2004;23:402-8.
30. Huettel SA, Song AW, McCarthy G. Functional Magnetic Resonance Imaging. Sunderland: Sinauer Ass, Inc., 2004.
31. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-8.